• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】20249

【品名】2,6-Diisopropylphenol

【CA登记号】2078-54-8

【 分 子 式 】C12H18O

【 分 子 量 】178.27432

【元素组成】C 80.85% H 10.18% O 8.97%

与该中间体有关的原料药合成路线共 4 条

合成路线1

该中间体在本合成路线中的序号:(VIII)

1) The reaction of (V) with SOCl2 or (COCl)2 in DMF affords the expected acyl chloride (VI), which is finally condensed with 2,6-diisopropylphenyl sulfamate (VII) by means of triethylamine in hot toluene to obtain Avasimibe. 2) The sulfamate (VII) can be obtained by condensation of 2,6-diisopropylphenol (VIII) with chlorosulfonyl isocyanate (IX) in refluxing toluene to give the isocyanate (X), which is hydrolyzed with water to the sulfamate (VII). compound is condensed with the previously described isocyanate (X) in refluxing THF to obtain Avasimibe. 3) Avasimibe can also be obtained by condensation of isocyanate (X) with Grignard reagent (XIII).

1 Sorbera, L.A.; Rabasseda, X.; Castañer, J.; Avasimibe . Drugs Fut 1999, 24, 1, 9.
2 Lee, H.T.; Picad, J.A.; Sliskovic, D.R.; Wierenga, W. (Pfizer Inc.); N-Acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents. EP 0698010; JP 1996510256; US 5491172; WO 9426702 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(V) 20240 2-(2,4,6-triisopropylphenyl)acetic acid C17H26O2 详情 详情
(VI) 20247 2-(2,4,6-triisopropylphenyl)acetyl chloride C17H25ClO 详情 详情
(VII) 20248 2,6-diisopropylphenylsulfamate C12H19NO3S 详情 详情
(VIII) 20249 2,6-Diisopropylphenol 2078-54-8 C12H18O 详情 详情
(IX) 14101 Chlorosulfonyl isocyanate 1189-71-5 CClNO3S 详情 详情
(X) 20251 2-[(isocyanatosulfonyl)oxy]-1,3-diisopropylbenzene C13H17NO4S 详情 详情
(XIII) 20243 bromo(2,4,6-triisopropylbenzyl)magnesium C16H25BrMg 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

The title compound was obtained by iodination of 2,6-diisopropylphenol (propofol) (I) employing either potassium iodide and hydrogen peroxide or iodonium chloride in HOAc.

1 Altomare, C.; Latrofa, A.; Usala, M.; Sanna, E.; Liso, G.; Franco, M.; Biggio, G.; Trapani, G.; Propofol analogues. Synthesis, relationships between structure and affinity at GABAA receptor in rat brain, and differential electrophysiological profile at recombinant human GABAA receptors. J Med Chem 1998, 41, 11, 1846.
2 Bonal, J.; et al. (Bobel246 SL); Use derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors. WO 9521610 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 20249 2,6-Diisopropylphenol 2078-54-8 C12H18O 详情 详情

合成路线3

该中间体在本合成路线中的序号:(I)

The title compound was obtained by Mannich reaction between 2,6-diisopropylphenol (I), morpholine (II) and formaldehyde, followed by conversion to the corresponding hydrochloride salt.

1 Cooke, A.; et al.; Water-soluble propofol analogues with intravenous anaesthetic activity. Bioorg Med Chem Lett 2001, 11, 7, 927.
2 Buchanan, K.; et al.; Novel water-soluble propofol analogs with intravenous anaesthetic activities. 222nd ACS Natl Meet (Aug 26 2001, Chicago) 2001, Abst MEDI 226.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 20249 2,6-Diisopropylphenol 2078-54-8 C12H18O 详情 详情
(II) 10388 Morpholine 110-91-8 C4H9NO 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

Methylation of 2,6-diisopropylphenol (I) with iodomethane and K2CO3 provides ether (II). Subsequent treatment with iodine and nitric acid gives rise to the diaryl iodonium compound (III), isolated as the corresponding tetrafluoroborate salt. 3,5-Dibromo-4-hydroxybenzoic acid (IV) is esterified with methanol and thionyl chloride to produce (V). Copper-promoted coupling between hydroxybenzoate (V) and the diaryl iodonium salt (III) leads to diaryl ether (VI). Finally, simultaneous cleavage of the methyl ether and ester groups of (VI) is achieved by means of boron tribromide in cold CH2Cl2

1 Baxter, J.D.; Goede, P.; Apriletti, J.W.; et al.; Structure-based design and synthesis of a thyroid hormone receptor (TR) antagonist. Endocrinology 2002, 143, 2, 517.
2 Baxter, J.D.; Scanlan, T.S.; Fletterick, R.J.; Wagner, R.L.; Kushner, P.J.; West, B.L.; Shiau, A.K.; Apriletti, J.W. (University of California, Oakland); Nuclear receptor ligands and ligand binding domains. CA 2314096; EP 1034184; US 6266622; WO 9926966 .
3 Brenneisen,P.; et al. (Ciba Geigy Corp.); Nuclear receptor ligands and ligand binding domains. DE 1932690; DE 1935338; US 3839582 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 20249 2,6-Diisopropylphenol 2078-54-8 C12H18O 详情 详情
(II) 60874 2,6-diisopropylphenyl methyl ether; 1,3-diisopropyl-2-methoxybenzene C13H20O 详情 详情
(III) 60875 bis(3,5-diisopropyl-4-methoxyphenyl)iodonium C26H38IO2 详情 详情
(IV) 10115 3,5-Dibromo-4-hydroxybenzoic acid 3337-62-0 C7H4Br2O3 详情 详情
(V) 10116 methyl 3,5-dibromo-4-hydroxybenzoate 41727-47-3 C8H6Br2O3 详情 详情
(VI) 60876 methyl 3,5-dibromo-4-(3,5-diisopropyl-4-methoxyphenoxy)benzoate C21H24Br2O4 详情 详情
Extended Information